SABERES ANCESTRALES INDIGENAS: UNA COSMOVISIÓN TRANSDISCIPLINARIA PARA EL DESARROLLO SUSTENTABLE

El propósito de la investigación fue generar una cosmovisión transdisciplinaria de los saberes ancestrales indígenas para el desarrollo sustentable. En lo metodológico el estudio se enmarco en el paradigma postpositivista, con enfoque fenomenológico, utilizándose el método etnográfico, el escenario de estudio estuvo representado por cinco ancestros de comunidades indígenas de los municipios Pedro Camejo, Achaguas y Rómulo Gallegos del estado Apure, entre las técnicas de recolección de la información se implementó la entrevista semiestructurada y la observación participante, como técnicas de análisis de la información se utilizó la categorización, estructuración y triangulación. De la realidad estudiada emergieron unas categorías y subcategorías que contribuyeron con el cimiento de una cosmovisión transdisciplinaria de los saberes ancestrales indígenas para el desarrollo sustentable, que recoge las premisas de lo formativo, cultural y social, económico, ambiental, desarrollo sustentable y transdisciplinariedad que emerge de estas prácticas enraizadas en los pueblos originarios como formas de vida y de desarrollo cultural

Better vaccines for bad viruses: the case of Porcine Circovirus Type 2 (PCV2)

Motivation: There are viruses of complex biology against which it is arduous to develop vaccines. Some examples in humanhealth are the HIV or Hepatitis C viruses, among others. Recombinant vaccines promised to be the solution of themanufacturing problems of vaccines based on live-attenuated viruses. However, recombinant vaccines raise a decent humoralcomponent of immunity but not the same potent T cell-mediated immunity of a replicative vaccine or a natural infection. Inanimal health, Porcine Circovirus Type 2 (PCV2) has spread all over the world because using a live-attenuated vaccine isunsafe and shows manufacturing problems, while the currently marketed killed or recombinant vaccines are able to preventpiglets from showing disease, but because of the poor cell-mediated immunity do not promote total viral clearance. In thisproject, we are testing the manufacturing of three candidates of recombinant vaccines, which have been modified to raise amore effective cell-mediated immunity, with the aim of providing to the animal health sector a definitive solution against PCV2.The strategies used in this project are diverse and could be applied to develop vaccines against human viruses of complexbiology.Methods: For sustainable antigen manufacturing in an eukaryotic system, we have created and characterized baculovirusesable to express the candidates in either insect cells or insect larva of Trichoplusia ni. We have compared the fermentativemanufacturing platform against a linearly scalable platform, by using both cells and larvae for antigen production and recoveryto a high degree of purity.Results: After development of specific purification protocols, the three recombinant antigens were manufactured successfullyin either platform, reaching purities of 75-85 %. However, the recovery yield of the antigens from the whole insect larvae was10-fold higher. Immunogenicity of the antigens has been tested in vitro and is currently being tested in vivo.Conclusions: In this project we have demonstrated that stable and properly folded recombinant vaccines engineeredspecifically to raise a potent T-cell mediated immunity could be manufactured in either insect cells or larvae by usingthe baculovirus expression technology. Having an economically sustainable platform for manufacturing bettervaccines against viruses of complex biology both in animal and human healt

Efficient microwave-assisted production of furfural from C5 sugars in aqueous media catalysed by Bro¨nsted acidic ionic liquids

Small amounts of SO3H-functionalised room temperature synthesized ionic liquids efficiently dehydrate aqueous xylose to furfural under microwave heating at mild reaction conditions. The RT-ionic liquid catalysts were also found to be effective catalysts for the two step one-pot simultaneous hydrolysis and dehydration of a lignocellulosic waste biorefinery-derived syrup enriched in C5 sugar oligomer

IAA : Información y actualidad astronómica (31)

Sumario : Relámpagos en las alturas.-- El misterio de Di Herculis.-- Jets en galaxias activas.-- HISTORIAS DE ASTRONOMÍA. Los All-Star de la física.-- DECONSTRUCCIÓN Y otros ENSAYOS. Cómo “encender” un cuásar .-- EL “MOBY DICK” DE... María Rosa Zapatero Osorio (CAB, CSIC-INTA).-- ACTUALIDAD.-- ENTRE BASTIDORES.-- CIENCIA: PILARES E INCERTIDUMBRES : El Sistema Solar: ¿conocemos de verdad nuestro vecindario?.-- ACTIVIDADES IAA, AGENDA Y RECOMENDADOS.N

Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells

HIV represents a persistent infection which negatively alters the immune system. New tools to reinvigorate different immune cell populations to impact HIV are needed. Herein, a novel nanotool for the specific enhancement of the natural killer (NK) immune response towards HIV-infected T-cells has been developed. Bispecific Au nanoparticles (BiAb-AuNPs), dually conjugated with IgG anti-HIVgp120 and IgG anti-human CD16 antibodies, were generated by a new controlled, linker-free and cooperative conjugation method promoting the ordered distribution and segregation of antibodies in domains. The cooperatively-adsorbed antibodies fully retained the capabilities to recognize their cognate antigen and were able to significantly enhance cell-to-cell contact between HIV-expressing cells and NK cells. As a consequence, the BiAb-AuNPs triggered a potent cytotoxic response against HIV-infected cells in blood and human tonsil explants. Remarkably, the BiAb-AuNPs were able to significantly reduce latent HIV infection after viral reactivation in a primary cell model of HIV latency. This novel molecularly-targeted strategy using a bispecific nanotool to enhance the immune system represents a new approximation with potential applications beyond HIV.This study was supported by the Spanish Secretariat of Science and Innovation and FEDER funds (grants SAF2015-67334-R and RTI2018-101082-B-I00 [MINECO/FEDER]), American National Institutes of Health (grant R21AI118411 to M.B), an unrestricted research grant from Bristol-Myers Squibb S.A.U (PfC-2015-AI424-564) to M.B, the Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI17/01470) to M.G and the Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI14/01058) to J.G.P, a research grant from Gilead Sciences (GLD17-00204 and GLD19-00084) to M.B, GeSIDA and the Spanish AIDS network “Red Temática Cooperativa de Investigación en SIDA” (RD16/0025/0007). The Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179) to M.B and J.G.P (CPII15/00014). The “Pla estratègic de recerca i innovació en salut” (PERIS), from the Catalan Government to M.G. The Spanish Secretariat of Science and Innovation Ph.D. fellowship to A.A-G (BES-2016-076382), AGAUR-FI-B-00582 Ph.D. fellowship from the Catalan Government to O.BL, and PIF-UAB Ph.D. fellowship from Universitat Autònoma de Barcelona to R.SL.Peer reviewe

Perspectivas actuales de los sujetos de derecho

En este volumen se recogen las intervenciones del II Seminario Internacional Permanente del Departamento de Derecho Internacional, Eclesiástico y Filosofía del Derecho de la Universidad Carlos III de Madrid que se desarrolló en el curso académico 2010-2011Presentación / Rafael de Asís Roig. - Algunas reflexiones sobre el individuo en Derecho Internacional / Castor Díaz Barrado. - Sobre capacidad y derechos / Rafael de Asís Roig. - Derecho Común versus Derecho Especial : el individuo como sujeto del derecho de libertad de conciencia y religiosa en España y Portugal / Alejandro Torres Gutiérrez. - Las empresas transnacionales como actores y sujetos «potenciales» en la sociedad internacional / Romualdo Bermejo García. - Las minorías religiosas como sujetos de derechos en España : un sistema de desigualdad / José María Contreras Mazario. - Los colectivos como sujetos de Derecho / Olga Sánchez Martínez. - De «protectorado internacional» a Estado «protegido» (¿Es Kosovo un Estado?) / Cesáreo Gutiérrez Espada - Contra el Derecho Internacional : imperialismo americano y subjetividad jurídica / Cristina García Pascual. - Cooperación constitucional e internacionalidad de la Iglesia católica / Paulino Pardo Prieto. - El individuo como titular de la libertad religiosa : aproximación a un problema de filosofía jurídica / Fernando Arlettaz. - La adopción de un procedimiento de comunicaciones individuales : ¿asignatura pendiente en la consolidación de la «subjetividad internacional del niño»? / Mª del Rosario Carmona Luque. - La persona con discapacidad como sujeto de derechos : análisis desde dos modelos / Patricia Cuenca Gómez. - Los sujetos de Derecho Internacional y los desastres internacionales / Carlos R. Fernández Liesa. - Los inmigrantes como colectivo : ¿son sujeto de Derecho Internacional? / Rosana Garciandía Garmendia. - La empresa : ¿Sujeto de Derecho Internacional? : Importancia de la cuestión / Hilda Garrido Suárez. - La tolerancia étnica y religiosa en los proyectos para la independencia del Estado búlgaro de la dominación otomana, el punto de partida del concepto legal sobre la protección de los derechos fundamentales de las minorias en Bulgaria / Ángel Hristov Kolev. - El régimen jurídico del profesorado y de la asignatura de religión católica en la escuela pública. Comentario a la STC 51/2011 de 14 de abril / Andrés Murcia González. - El sujeto de derecho en Pufendorf / Antonio Pele. - ¿Puede un sujeto de Derecho Internacional juzgar a otro? Algunas consideraciones sobre la inmunidad de jurisdicción de las organizaciones internacionales / Juan Jorge Piernas Lópe

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome

The aim was to assess the ability of nasopharyngeal SARS-CoV-2 viral load at first patient’s hospital evaluation to predict unfavorable outcomes. We conducted a prospective cohort study including 321 adult patients with confirmed COVID-19 through RT-PCR in nasopharyngeal swabs. Quantitative Synthetic SARS-CoV-2 RNA cycle threshold values were used to calculate the viral load in log10 copies/mL. Disease severity at the end of follow up was categorized into mild, moderate, and severe. Primary endpoint was a composite of intensive care unit (ICU) admission and/or death (n = 85, 26.4%). Univariable and multivariable logistic regression analyses were performed. Nasopharyngeal SARS-CoV-2 viral load over the second quartile (≥ 7.35 log10 copies/mL, p = 0.003) and second tertile (≥ 8.27 log10 copies/mL, p = 0.01) were associated to unfavorable outcome in the unadjusted logistic regression analysis. However, in the final multivariable analysis, viral load was not independently associated with an unfavorable outcome. Five predictors were independently associated with increased odds of ICU admission and/or death: age ≥ 70 years, SpO2, neutrophils > 7.5 × 103/µL, lactate dehydrogenase ≥ 300 U/L, and C-reactive protein ≥ 100 mg/L. In summary, nasopharyngeal SARS-CoV-2 viral load on admission is generally high in patients with COVID-19, regardless of illness severity, but it cannot be used as an independent predictor of unfavorable clinical outcome

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection induces an exacerbated inflammation driven by innate immunity components. Dendritic cells (DCs) play a key role in the defense against viral infections, for instance plasmacytoid DCs (pDCs), have the capacity to produce vast amounts of interferon-alpha (IFN-α). In COVID-19 there is a deficit in DC numbers and IFN-α production, which has been associated with disease severity. In this work, we described that in addition to the DC deficiency, several DC activation and homing markers were altered in acute COVID-19 patients, which were associated with multiple inflammatory markers. Remarkably, previously hospitalized and nonhospitalized patients remained with decreased numbers of CD1c+ myeloid DCs and pDCs seven months after SARS-CoV-2 infection. Moreover, the expression of DC markers such as CD86 and CD4 were only restored in previously nonhospitalized patients, while no restoration of integrin β7 and indoleamine 2,3-dyoxigenase (IDO) levels were observed. These findings contribute to a better understanding of the immunological sequelae of COVID-19